115 related articles for article (PubMed ID: 3164670)
1. In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Kern W; Gulden H; Vanek E; Kurrle E
Chemotherapy; 1988; 34(2):117-26. PubMed ID: 3164670
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Forsgren A
Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Espinoza AM; Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):663-70. PubMed ID: 3293524
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Grimm H
Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
[TBL] [Abstract][Full Text] [Related]
6. RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenem.
Aldridge KE; Schiro DD; Sanders CV
Diagn Microbiol Infect Dis; 1987 May; 7(1):9-19. PubMed ID: 3121244
[TBL] [Abstract][Full Text] [Related]
7. Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
Fass RJ; Barnishan J; Ayers LW
J Antimicrob Chemother; 1995 Aug; 36(2):343-53. PubMed ID: 8522464
[TBL] [Abstract][Full Text] [Related]
8. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Erdem I; Kaynar-Tascioglu J; Kaya B; Goktas P
Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Periti P; Mazzei T; Nicoletti P
Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antibacterial activity of piperacillin/quinolone combinations].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
Chantot JF; Bryskier A
J Antimicrob Chemother; 1985 Oct; 16(4):475-84. PubMed ID: 3864775
[TBL] [Abstract][Full Text] [Related]
14. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
[TBL] [Abstract][Full Text] [Related]
15. Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.
Bustamante CI; Drusano GL; Wharton RC; Wade JC
Antimicrob Agents Chemother; 1987 Apr; 31(4):632-4. PubMed ID: 3111357
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of 7 mycobacterial species to new quinolones].
Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
[TBL] [Abstract][Full Text] [Related]
20. [Ciprofloxacin in combination with other antimicrobial substances].
Shah PM; Mellinghoff D; Stille W
Arzneimittelforschung; 1988 Mar; 38(3):411-5. PubMed ID: 3164186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
